... in stage I lung cancer N Engl J Med 2008;358(11):1118 –28. 29 Koo HK, Jin SM, Lee CH, et al Factors associated with recurrence in patients with curatively resected stage I-II lung cancer Lung Cancer ... resected stage I non-small cell lung cancer Chest 2013;143(6):1626 –34. 7 Hung JJ, Jeng WJ, Hsu WH, et al Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung ... invasive adenocarcinoma, LVI lymphovascular invasion, VPI visceral pleural invasion, LUAD lung adenocarcinoma, LUSC lung squamous carcinoma, LASC lung adenosquamous carcinoma, NSCLC non-small-cell lung
Ngày tải lên: 17/06/2020, 03:11
... patients with non-small cell lung cancer: a systematic review Lung Cancer 2013;81(1):11 –26. 59 Myrdal G, Valtysdottir S, Lambe M, Stahle E Quality of life following lung cancer surgery Thorax ... Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis Lung Cancer 2015;87(3):283 –9. 3 Chang ... Aerts J, Nuyttens J, Bogers A, Takkenberg JJM Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancerdagger Interact Cardiovasc Thorac Surg 2017;25:278
Ngày tải lên: 24/07/2020, 00:19
Báo cáo khoa học: " Validation of an elastic registration technique to estimate anatomical lung modification in NonSmall-Cell Lung Cancer Tomotherapy" docx
... anatomical changes. In the cas e of Non-Small-Cell Lung Cancer (NSCLC), lung parenchyma can significantly modifyitsvolumeandshape[3].Asadirectconse- quence, in lungs, dose discrepancies can oc cur between ... left lung atelectasis and mediastinum shift in the direction of the left lung: while the rigidly realigned MVCT lung presented a lung volume systematicall y smaller than the initial kVCT lung ... Access Validation of an elastic registration technique to estimate anatomical lung modification in Non- Small-Cell Lung Cancer Tomotherapy Elena Faggiano 1,2 , Giovanni M Cattaneo 3 , Cristina Ciavarro
Ngày tải lên: 09/08/2014, 09:20
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer
... 2Non-small-cell lung carcinoma (NSCLC) is one of the most common cancers worldwide, contributing for of lung cancer, mainly subdivided into two types: squamous cell carcinoma (SCC) and non-squamous cell ... survivorship statistics, 2016 CA Cancer J Clin 2016;66(4):271 –89. 4 Midha A, Dearden S, Mc Cormack R EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: A systematic ... Association for the Study of Lung Cancer, and the Association for Molecular Pathology J Mol Diagn. 2018;20(2):129 –59. 10 NCCN Guidelines Version 4 2019 Non-small cell lung cancer. 11 Novello S, Barlesi
Ngày tải lên: 17/06/2020, 11:13
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in nonsmall cell lung cancer patients
... domain containing 5 (SETD5), Non-small cell lung cancer, Invasion, ERK signaling, Prognosis Background Non-small cell lung cancer (NSCLC) is a malignant cancers [1] It affects mainly adults > ... features in non-small cell lung cancer (NSCLC) Clinical parameters Number ( N = 147) SETD5 expression χ2 P Positive Negative Squamous cell carcinoma Adenocarcinoma 92 46 46 Large cell carcinoma 1 ... guidelines) Non-small cell lung Cancer Versiom 3.2018 Fort Washington: National Comprehensive Cancer Network; 2018. 3 Siegel RL, Miller KD, Jemal A Cancer statistics, 2018 CA Cancer J Clin 2018;68:7
Ngày tải lên: 17/06/2020, 16:59
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected nonsmall cell lung cancer
... role of TSP-1 in cancer cell proliferation and metastasis [43] Inhibitory effect of TSP-1 in cancer cell proliferation and metastasis comes from studies in human lung cancer cell lines, whereas ... Public Domain Dedication waiver Trang 2Lung cancer, with non-small cell lung cancer (NSCLC) constituting 85 % of cases, remains the most prevalent and lethal cancer worldwide [1] Surgery is the ... classified 92 % of the patients as having stage I to IIIA, including 47 % stage I, 21 % stage II, and 24 % stage IIIA Thirteen patients (8 %) were classified as having stage IIIB The majority (74 %) of
Ngày tải lên: 20/09/2020, 14:15
Personalized medicine for effective treatment of nonsmall-cell lung cancer with targeted therapiesa
... medicine, targeted therapy, non-small-cell lung cancer, treatment. Citation: Duong Hong Quan, 2020 Personalized medicine for effective treatment of non-small-cell lung cancer with targeted therapies ... cell lung cancer (SCLC) accounts for 85% and 15% of all patients with lung cancer, respectively (Travis et al., 2013) NSCLC is divided into subtypes, being adenocarcinoma (ADC) and squamous cell ... advanced stages and consequently, patients have a very poor prognosis (Bray et al., 2015; Gridelli et al., 2015) Based on histopathological features, non-small-cell lung cancer (NSCLC) and small cell
Ngày tải lên: 27/09/2020, 13:34
Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
... 300060, PR China Trang 2Lung cancer is the cancer with the world’s highest mor-bidity and mortality [1] Non-small cell lung cancer (NSCLC) accounts for 80–85% of the cases of lung can-cer NSCLC mainly ... metastasis in nonsmall cell lung cancer Neuro-Oncology 2010;12:1193 –9. 18 Enomoto Y, Takada K, Hagiwara E, Kojima E Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma ... pulmonary adenocarcinoma J Cancer Res Clin Oncol 2009;135:1647 –54. 15 Iuchi T, Shingyoji M, Itakura M, Yokoi S, Moriya Y, Tamura H, et al Frequency of brain metastases in non-small-cell lung cancer,
Ngày tải lên: 28/09/2020, 09:27
Blood test shows high accuracy in detecting stage I non-small cell lung cancer
... Early stage lung cancer, Detection, Biomarkers, Proteomics, Diagnostic tests, Non-small cell lung cancer Background Lung cancer is a pervasive disease that is commonly di-agnosed at a late stage ... Smoker or non-smoker Any cancer diagnosis Non-Smoker Healthy Smokers, any cancer diagnosis NSCLC, (Stage I-II) Stage I-II; smoker or non-smoker Stage III-IV lung cancer Other Cancers Breast, colon-rectal, ... rate; FPR: False positive rate; LC: Lung cancer; LCDT1: Lung cancer detector test 1; LDCT: Low-dose spiral computed tomography; NSCLC: Non-small cell lung cancer; PET: Positron emission tomography;
Ngày tải lên: 17/06/2020, 03:04
Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis
... platinum easier Keywords: Small cell lung cancer, Extensive-staged, Irinotecan, Etoposide, Meta-analysis Background Lung cancer, which represents 13% of newly diagnosed cancers worldwide, is the most ... most common tumor type [1] Small cell lung cancer (SCLC) accounts for approxi-mately 15% of new cases of annually diagnosed lung cancer, and up to 25% of lung cancer deaths each year [2] Approximately ... were used to perform an electronic search by combining following words: “small cell lung cancer” or “small cell lung carcinoma,” “irinotecan” or “CPT-11,” and “etoposide” or “VP-16” To limit
Ngày tải lên: 03/07/2020, 01:36
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective
... advanced non-small-cell lung cancer. J Clin Oncol 2002;20(21):4285 –91. 17 Morgensztern D, Waqar S, Subramanian J, Gao F, Govindan R Improving survival for stage IV non-small cell lung cancer: a surveillance, ... non-small-cell lung cancer N Engl J Med 2002;346(2):92 –8. 25 Ouyang WW, Su SF, Hu YX, Lu B, Ma Z, Li QS, Li HQ, Geng YC Radiation dose and survival of patients with stage IV non-small cell lung cancer ... Status; NSCLC: Non-small cell lung cancer; OS: Overall survival; PD: Progressive disease; PR: Partial response; PSM: Propensity-score matching; SCLC: Small-cell lung cancer; SD: Stable disease
Ngày tải lên: 20/09/2020, 18:50
Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: A systematic review and meta-analysis
... colorectal cancer (CRC), lung cancer, gastric can-cer and gynecologic neoplasms [6–9] NCCN guidelines recommend IBC as first-line treatment of metastatic CRC and extensive-stage small-cell lung cancer ... Background Lung cancer is the leading cause of cancer-related deaths worldwide, and approximately 80 % of patients with lung cancer are non-small cell lung cancer (NSCLC) Two-thirds of patients with ... with stage IIIB/IV NSCLC However, the non-hematological toxicity of IBC must be considered Keywords: Irinotecan, Chemotherapy, Non-small cell lung cancer, Meta-analysis Background Lung cancer
Ngày tải lên: 22/09/2020, 23:03
Nomogram model for predicting causespecific mortality in patients with stage I small-cell lung cancer: A competing risk analysis
... of surgery for stage I small cell lung cancer J Thorac Oncol 2010;5(2):215 –9. 17 Schneider BJ, Saxena A, Downey RJ Surgery for early-stage small cell lung cancer J Natl Compr Cancer Netw 2011;9(10):1132 ... Rotman M Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? CANCER-AM CANCER SOC 2010;116(5):1350 –7. 13 Brock MV, Hooker CM, Syphard ... information for stage I SCLC patients Keywords: SCLC, Competing risks, Cumulative incidence, Nomogram Background Small-cell lung cancer (SCLC) is one of the two main types of lung cancer with short
Ngày tải lên: 22/09/2020, 23:13
Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: A meta-analysis of published studies involving 32 studies
... included Non-Small-Cell Lung Cancer (‘Carcinoma, Non-Non-Small-Cell Lung’ or ‘Carcinoma, Non Small Cell Lung’ or ‘Carcin-omas, Small-Cell Lung’ or ‘Lung Carcinoma, Non-Small-Cell’ or ‘Lung Carcinomas, ... ‘Lung Carcinomas, Non-Non-Small-Cell’ or ‘Small-Cell Lung Carcinomas’ or ‘Carcinoma, Non-Small Cell Lung’ or ‘Non-Non-Small-Cell Lung Carcinoma’ or ‘Non Small Cell Lung Carcinoma’ or ‘NSCLC’), Ki-67 ... in patients diagnosed at stage I [1] Non-small cell lung cancer (NSCLC), of which adenocarcinoma (ADC) and non-ADC (including squamous cell carcinoma (SQCC), large cell lung carcinoma (LCC), and
Ngày tải lên: 28/09/2020, 10:04
The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: Based on the three-dimensional conformal radiotherapy technique and institutional
... non-small-cell lung cancer Lung Cancer 2013;80:350 –2. 7 Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III non-small-cell lung cancer ... non-small-cell lung cancer: two meta-analyses of individual patient data Lancet 2010;375:1267 –77. 4 PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer: ... right-sided lung cancers [18] The CTV for left-lung cancers includes the bronchial stump (BS) and lymph node stations (LNS) 2R, 2 L, 4R, 4 L, 5, 6, 7, and 10 to 11 L; and the CTV for right-lung cancers
Ngày tải lên: 29/09/2020, 16:11
Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer
... Kondo6 Abstract Background: Lung cancer is one of the leading causes of cancer death worldwide Even with complete resection, the prognosis of early-stage non-small cell lung cancer is poor due to local ... early-stage non-small cell lung cancer Thus, a combination of activity of cyclin-dependent kinases 1 and 2 is useful in decision-making regarding treatment strategies for non-small cell lung cancer ... cell lung cancer, Cyclin-dependent kinase, Surgical resection, Recurrence, Mortality Background Lung cancer is one of the leading causes of cancer death worldwide Despite recent advances in cancer
Ngày tải lên: 14/10/2020, 16:57
Báo cáo khoa học: " Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC)" pptx
... Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC) Matthias Guckenberger*, Kurt Baier, Anne Richter, Juergen Wilbert and Michael ... of surface-based deformable image registration (DR) for adaptive radiotherapy of non-small cell lung cancer (NSCLC) Methods: Based on 13 patients with locally advanced NSCLC, CT images acquired ... relationship between the target and the parotid glands [8] Similar findings were made for non-small-cell lung cancer (NSCLC), where a continuous tumor regression during radiotherapy was observed [9] This
Ngày tải lên: 09/08/2014, 10:20
Báo cáo khoa học: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer" pps
... chemoradiotherapy in non-small cell lung cancer (Review). In The Cochrane Library Vol- ume 1. Wiley; 2005:1-37. 25. Vokes EE: Optimal therapy for unresectable stage III non- small-cell lung cancer. J Clin Oncol ... for stage I Nonsmall cell lung carcinoma. Cancer 2004, 101:1623-1631. 54. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Leb- esque J: Acute esophageal toxicity in non-small cell lung ... in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo- Cancerologie (GFPC). Lung Cancer 2005, 47:395-404. 42. Vokes E, Herndon
Ngày tải lên: 09/08/2014, 10:21
Báo cáo y học: "proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database" docx
... non-small cell lung cancer comprise the majority of cases annotated within the database. Other cancers contained in the database include small cell lung cancer, mesothelioma, esophageal cancer, ... deaths from lung cancer [4]. Lung cancer has traditionally been dichotomized into two groups based on the histological features of the tumor: small cell and non-small cell lung cancer. NSCLC is ... this article as: Surati et al.: Proteomic characterization of non-small cell lung cancer. .. cell lung cancer in a comprehensive translational thoracic oncology database
Ngày tải lên: 10/08/2014, 09:22
báo cáo khoa học: " Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer" pdf
... levels in normal lung tissues, and nonsmall cell lung cancers Jpn J Cancer Res 1999, 90:1338-43. 11 Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases ... human adenocarcinoma of the lung Lung Cancer 2000, 30:73-81. 4 Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimäki A: Expression of cyclooxygenase-2 in human lung carcinoma Cancer ... squamous cell lung cancer and 70% of adenocarcinomas [25] However, the involvement of COX-2 in the angiogenic response of tumor cells and the role of COX-2 in up-regulating VEGF release by NSCLC cells
Ngày tải lên: 10/08/2014, 10:20